# A Single-center, Prospective,Randomized Study of Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Dual Anti-platelet Therapy After Coronary Artery Bypass Grafting

> **NCT02330640** · PHASE4 · COMPLETED · sponsor: **Chinese Academy of Medical Sciences, Fuwai Hospital** · enrollment: 137 (actual)

## Conditions studied

- Antiplatelet Therapy of Coronary Artery Bypass

## Interventions

- **DRUG:** ticagrelor
- **DRUG:** clopidogrel
- **DRUG:** asprin

## Key facts

- **NCT ID:** NCT02330640
- **Lead sponsor:** Chinese Academy of Medical Sciences, Fuwai Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2016-10
- **Final completion:** 2016-10-01
- **Target enrollment:** 137 (ACTUAL)
- **Last updated:** 2017-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02330640

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02330640, "A Single-center, Prospective,Randomized Study of Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Dual Anti-platelet Therapy After Coronary Artery Bypass Grafting". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02330640. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*